These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8110443)
1. The importance of non-biological factors in influencing the outcome of clinical trials. Gaebel W Br J Psychiatry Suppl; 1993 Dec; (22):45-50. PubMed ID: 8110443 [TBL] [Abstract][Full Text] [Related]
2. Relapse prevention and recovery in the treatment of schizophrenia. Schooler NR J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093 [TBL] [Abstract][Full Text] [Related]
3. Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. Lieberman JA; Koreen AR; Chakos M; Sheitman B; Woerner M; Alvir JM; Bilder R J Clin Psychiatry; 1996; 57 Suppl 9():5-9. PubMed ID: 8823344 [TBL] [Abstract][Full Text] [Related]
4. [Planning of psychotropic drug trials. Control of interfering factors]. Schmocker AM Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):149-51. PubMed ID: 360239 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Leucht S; Heres S J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of treatment effects in schizophrenia. Stroup TS Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379 [TBL] [Abstract][Full Text] [Related]
8. Factors which can make patients difficult to treat. Kane JM Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650 [No Abstract] [Full Text] [Related]
9. Partial response to antipsychotic treatment: the patient with enduring symptoms. Emsley RA J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194 [TBL] [Abstract][Full Text] [Related]
13. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ; Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590 [TBL] [Abstract][Full Text] [Related]
14. The relationship between patient satisfaction and treatment outcomes in schizophrenia. Chue P J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986 [TBL] [Abstract][Full Text] [Related]
15. Schizophrenia: recent advances in psychopharmacology. Sharma T Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500 [No Abstract] [Full Text] [Related]
16. Subjective well-being and quality of life under atypical antipsychotic treatment. Karow A; Naber D Psychopharmacology (Berl); 2002 Jun; 162(1):3-10. PubMed ID: 12107610 [TBL] [Abstract][Full Text] [Related]
17. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C; Bret P; Bret MC; Queuille E Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [TBL] [Abstract][Full Text] [Related]
18. [Problems in evaluating new antipsychotic drugs]. Fleischhacker WW Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969 [TBL] [Abstract][Full Text] [Related]
19. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia. Weiss EM; Bilder RM; Fleischhacker WW Psychopharmacology (Berl); 2002 Jun; 162(1):11-7. PubMed ID: 12107611 [TBL] [Abstract][Full Text] [Related]
20. Management strategies for the treatment of schizophrenia. Kane JM J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]